对类风湿性关节炎的全面见解:病理生理学,当前的治疗方法和草药替代方案,以有效管理疾病
Amrita Chatterjee1, Monisha Jayaprakasan1, Anirban Kr Chakrabarty2
1Department of Chemistry and Chemical Biology, Indian Institute of Technology (Indian School of Mines), Dhanbad, India.
Phytotherapy research : PTR
|March 24, 2024
概括
类风湿性关节炎涉及免疫系统过度活跃攻击关节. 本综述探讨药用草药作为潜在的治疗方法来克服传统治疗的副作用.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 类风湿病学 类风湿病学
背景情况:
- 风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,由于免疫系统过度活跃,导致关节炎症.
- 在RA中,自动反应性抗体错误地向自我抗原,导致突关节疼痛和胀.
- 目前的RA治疗有局限性和不良影响,需要替代疗法.
研究的目的:
- 审查类风湿性关节炎中免疫失调的情况.
- 分析RA所涉及的病理生理学和信号通路.
- 评估当前和未来的治疗策略,重点是药用草药.
主要方法:
- 基于文献的科学文章的评论.
- 在RA中分析免疫耐受性,病理生理学和信号通路.
- 评估植物药及其对自身免疫性疾病的治疗潜力.
主要成果:
- 失调的免疫耐受性和复杂的信号通路有助于RA的发展和进展.
- 药用草药含有生物活性植物化学物质,有可能用于补充RA治疗.
- 需要进一步的研究来了解草药治疗的疗效和机制.
结论:
- 对于管理类风湿性关节炎的新型治疗方法有显著的需求.
- 药用草药为开发植物药物治疗RA等自身免疫性疾病提供了有前途的途径.
- 了解草药化合物的药理动力学机制对于其临床应用至关重要.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Autoimmune Disorders
430
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
430
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424


